Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today reported financial results for the third quarter ended September 30, 2025, ...
Amazon's $38 billion investment in OpenAI marks a significant step in AI development, offering extensive cloud resources to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback